Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
T Yasuda, M Kawasuji, N Sakakibara, K Ueyama, H Kasajima, Y Watanabe, M Ito, M Shimiz. [A case of left ventricular aneurysm associated with acromegaly]. Kyobu geka. The Japanese journal of thoracic surgery. vol 46. issue 7. 1993-08-20. PMID:8336439. |
in order to safely operate, it is important to control serum gh levels and pay special attention to the well-known complications of acromegaly such as diabetes mellitus and hypertension. |
1993-08-20 |
2023-08-12 |
Not clear |
S J Brockmeier, M Buchfelder, R Fahlbusc. TRH/GnRH test in acromegaly. Long-term follow-up experience with successfully treated patients. Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme. vol 25. issue 5. 1993-08-17. PMID:8330864. |
we investigated the rate of recurrence in acromegaly in 20 patients who were found to have a trh and gnrh induced gh response postoperatively after primarily successful transsphenoidal selective adenomectomy in a retrospective study. |
1993-08-17 |
2023-08-12 |
Not clear |
S J Brockmeier, M Buchfelder, R Fahlbusc. TRH/GnRH test in acromegaly. Long-term follow-up experience with successfully treated patients. Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme. vol 25. issue 5. 1993-08-17. PMID:8330864. |
we conclude that, in contrast to previous studies, a stimulation of gh in the trh/gnrh test does not necessarily predict likely recurrence of acromegaly in patients with an adequate suppression of gh during an ogtt following operative microsurgical treatment. |
1993-08-17 |
2023-08-12 |
Not clear |
P G Chiodini, R Attanasio, R Cozzi, D Dallabonzana, G Oppizzi, P Orlandi, S Strada, A Liuzz. CV 205-502 in acromegaly. Acta endocrinologica. vol 128. issue 5. 1993-07-23. PMID:8100375. |
we conclude that in acromegaly chronic treatment with this new dopaminergic drug has a gh- and prl-lowering effect that is similar to but more prolonged than that of bromocriptine, and normal or near-normal gh and igf-i levels may be obtained in a few patients with b.i.d. |
1993-07-23 |
2023-08-12 |
Not clear |
G Tallen, S Fehr, W Saeger, H Uhlig, D K Lüdeck. Detection of growth hormone, prolactin and human beta-chorionic gonadotropin mRNA in growth hormone-secreting pituitary adenomas and in prolactin-secreting pituitary adenomas by in situ hybridization using a non-isotopic detection method. Acta endocrinologica. vol 128. issue 5. 1993-07-23. PMID:8317187. |
a non-isotopic in situ hybridization method with digoxigenin-labelled probes was used to examine growth hormone (gh), prolactin (prl) and human beta-chorionic gonadotropin (beta-hcg(lh)) gene expression in 63 pituitary tumours in acromegaly and 20 adenomas in hyperprolactinaemia. |
1993-07-23 |
2023-08-12 |
human |
G Tallen, S Fehr, W Saeger, H Uhlig, D K Lüdeck. Detection of growth hormone, prolactin and human beta-chorionic gonadotropin mRNA in growth hormone-secreting pituitary adenomas and in prolactin-secreting pituitary adenomas by in situ hybridization using a non-isotopic detection method. Acta endocrinologica. vol 128. issue 5. 1993-07-23. PMID:8317187. |
in all 63 adenomas in acromegaly, gh mrna was revealed in 59 prl mrna and in 36 beta-hcg(lh) mrna. |
1993-07-23 |
2023-08-12 |
human |
K Landin, B Petruson, K E Jakobsson, B A Bengtsso. Skeletal muscle sodium and potassium changes after successful surgery in acromegaly: relation to body composition, blood glucose, plasma insulin and blood pressure. Acta endocrinologica. vol 128. issue 5. 1993-07-23. PMID:8317188. |
the aim of this study was to investigate the skeletal muscle sodium/potassium (na/k) ratio in acromegaly before and 1 year after trans-sphenoidal removal of a growth hormone (gh)-secreting pituitary adenoma. |
1993-07-23 |
2023-08-12 |
Not clear |
K Landin, B Petruson, K E Jakobsson, B A Bengtsso. Skeletal muscle sodium and potassium changes after successful surgery in acromegaly: relation to body composition, blood glucose, plasma insulin and blood pressure. Acta endocrinologica. vol 128. issue 5. 1993-07-23. PMID:8317188. |
these changes seem to be mediated by a decreased gh effect on the na/k pump after successful trans-sphenoidal surgery in acromegaly. |
1993-07-23 |
2023-08-12 |
Not clear |
L Fredstorp, S Werne. Growth hormone and insulin-like growth factor-1 in blood and urine as response markers during treatment of acromegaly with octreotide: a double-blind placebo-controlled study. Journal of endocrinological investigation. vol 16. issue 4. 1993-07-20. PMID:8514980. |
growth hormone (gh), insulin-like growth factor-1 (igf-1) and prolactin (prl) in blood and urine were observed in 20 patients with acromegaly in a double-blind placebo-controlled 14-day clinical trial with the somatostatin analog octreotide. |
1993-07-20 |
2023-08-12 |
Not clear |
L Fredstorp, S Werne. Growth hormone and insulin-like growth factor-1 in blood and urine as response markers during treatment of acromegaly with octreotide: a double-blind placebo-controlled study. Journal of endocrinological investigation. vol 16. issue 4. 1993-07-20. PMID:8514980. |
in conclusion, this study indicates, that gh and igf-1 in blood are preferable to urinary gh and igf-1 as response markers during treatment of acromegaly with octreotide. |
1993-07-20 |
2023-08-12 |
Not clear |
L Fredstorp, S Werne. Growth hormone and insulin-like growth factor-1 in blood and urine as response markers during treatment of acromegaly with octreotide: a double-blind placebo-controlled study. Journal of endocrinological investigation. vol 16. issue 4. 1993-07-20. PMID:8514980. |
one disadvantage with urinary assessments of gh and igf-1 in acromegaly seems to be the relatively higher excretion in patients with diabetes mellitus. |
1993-07-20 |
2023-08-12 |
Not clear |
V Chabert-Orsini, G Simonin, T Brue, B Conte-Devolx, P Carayo. [Serum human growth hormone assay. Comparison of six assay kits]. Annales d'endocrinologie. vol 53. issue 4. 1993-07-16. PMID:1305801. |
we measured 695 sera obtained in short stature children (gh deficiency or normal gh secretory) and adults (normal, hypopituitarism or acromegaly). |
1993-07-16 |
2023-08-11 |
human |
J Hradec, J Marek, J Král, D Simper, J Spáci. Heart in pituitary diseases. Cor et vasa. vol 34. issue 2. 1993-07-08. PMID:1304450. |
once gh overproduction has been eliminated, cardiac hypertrophy and hypertension can be reversed to a certain stage, a finding highlighting the necessity of instituting treatment of acromegaly as early and as vigorous as possible. |
1993-07-08 |
2023-08-11 |
Not clear |
S Ezzat, S Melmed, D Endres, D R Eyre, F R Singe. Biochemical assessment of bone formation and resorption in acromegaly. The Journal of clinical endocrinology and metabolism. vol 76. issue 6. 1993-07-01. PMID:8501150. |
the effects of chronic gh and insulin-like growth factor-i (igf-i) excess on bone metabolism were examined by measuring serum markers of bone formation and urine markers of bone resorption as well as vertebral bone densities in patients with active acromegaly. |
1993-07-01 |
2023-08-12 |
Not clear |
A Giustina, M Schettino, S Bossoni, A R Bussi, M Doga, M Licini, W B Wehrenber. Arginine blocks the inhibitory effect of hydrocortisone on circulating growth hormone levels in patients with acromegaly. Metabolism: clinical and experimental. vol 42. issue 5. 1993-06-15. PMID:8492725. |
in patients with acromegaly, circulating growth hormone (gh) levels and gh responses to gh-releasing hormone (ghrh) are decreased by long-term administration of pharmacological doses of glucocorticoids. |
1993-06-15 |
2023-08-12 |
Not clear |
A Giustina, M Schettino, S Bossoni, A R Bussi, M Doga, M Licini, W B Wehrenber. Arginine blocks the inhibitory effect of hydrocortisone on circulating growth hormone levels in patients with acromegaly. Metabolism: clinical and experimental. vol 42. issue 5. 1993-06-15. PMID:8492725. |
infusion of hydrocortisone combined either with saline or arginine infusion on circulating gh levels in acromegaly. |
1993-06-15 |
2023-08-12 |
Not clear |
A Giustina, M Schettino, S Bossoni, A R Bussi, M Doga, M Licini, W B Wehrenber. Arginine blocks the inhibitory effect of hydrocortisone on circulating growth hormone levels in patients with acromegaly. Metabolism: clinical and experimental. vol 42. issue 5. 1993-06-15. PMID:8492725. |
our data show that arginine blocks the inhibitory effect of acute and sustained hypercortisolism on circulating gh levels in acromegaly. |
1993-06-15 |
2023-08-12 |
Not clear |
E F Adams, M Buchfelder, A Hüttner, S Moreth, R Fahlbusc. Recent advances in the molecular biology of growth-hormone secreting human pituitary tumours. Experimental and clinical endocrinology. vol 101. issue 1. 1993-05-24. PMID:8477819. |
in our own studies, we demonstrate that it is unlikely that a defect within the promoter region of the gh gene will prove to be a cause of excessive gh secretion in acromegaly. |
1993-05-24 |
2023-08-12 |
human |
H Kotzmann, P Bernecker, P Hübsch, P Pietschmann, W Woloszczuk, T Svoboda, G Geyer, A Luge. Bone mineral density and parameters of bone metabolism in patients with acromegaly. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research. vol 8. issue 4. 1993-05-20. PMID:8475795. |
to assess the effect of chronically elevated plasma growth hormone (gh) levels on bone metabolism and bone mineral density (bmd), 16 patients (10 females and 6 males) with a mean age of 49.1 +/- 13.2 years (range 33-68) with active acromegaly were studied and compared to a control group of 16 sex- and age-matched subjects. |
1993-05-20 |
2023-08-12 |
human |
G Turner, R C Brown, I Weeks, G E Butler, F N Creagh, J S Woodhea. Urinary growth hormone excretion as measured by a sensitive immunochemiluminometric assay. Annals of clinical biochemistry. vol 30 ( Pt 2). 1993-05-05. PMID:8466150. |
there was a good correlation between serum growth hormone (gh) and ugh concentrations in 20 patients with acromegaly and six volunteers following an intravenous injection of recombinant gh. |
1993-05-05 |
2023-08-12 |
human |